Literature DB >> 20554949

Beyond LDL cholesterol, a new role for PCSK9.

Omar N Akram, Adeline Bernier, Francine Petrides, Gida Wong, Gilles Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20554949     DOI： 10.1161/ATVBAHA.110.209007

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  17 in total

1.  The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2011-07-23

2.  Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts.

Authors:  Rishika De; Shefali S Verma; Emily Holzinger; Molly Hall; Amber Burt; David S Carrell; David R Crosslin; Gail P Jarvik; Helena Kuivaniemi; Iftikhar J Kullo; Leslie A Lange; Matthew B Lanktree; Eric B Larson; Kari E North; Alex P Reiner; Vinicius Tragante; Gerard Tromp; James G Wilson; Folkert W Asselbergs; Fotios Drenos; Jason H Moore; Marylyn D Ritchie; Brendan Keating; Diane Gilbert-Diamond
Journal:  Hum Genet       Date:  2016-11-15       Impact factor: 4.132

3.  Nontraditional serum lipid variables and recurrent stroke risk.

Authors:  Jong-Ho Park; Juneyoung Lee; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-09-18       Impact factor: 7.914

4.  Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation.

Authors:  Suzanne Benjannet; Josée Hamelin; Michel Chrétien; Nabil G Seidah
Journal:  J Biol Chem       Date:  2012-08-08       Impact factor: 5.157

Review 5.  PCSK9 Inhibitors: potential in cardiovascular therapeutics.

Authors:  Rose Q Do; Robert A Vogel; Gregory G Schwartz
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 6.  Modelling of atherosclerosis in genetically modified animals.

Authors:  Natalia V Mushenkova; Volha I Summerhill; Yulia Yu Silaeva; Alexey V Deykin; Alexander N Orekhov
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

7.  How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?

Authors:  Laszlo Mark; György Paragh; Istvan Karadi; Istvan Reiber; Gyula Pados; Zoltan Kiss
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

8.  Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.

Authors:  Enrique C Morales-Villegas; Germano Di Sciascio; Carlo Briguori
Journal:  Int J Hypertens       Date:  2011-03-28       Impact factor: 2.420

9.  Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation.

Authors:  Nabil G Seidah; Steve Poirier; Maxime Denis; Rex Parker; Bowman Miao; Claudio Mapelli; Annik Prat; Hanny Wassef; Jean Davignon; Katherine A Hajjar; Gaétan Mayer
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management.

Authors:  Osman Najam; Kausik K Ray
Journal:  Cardiol Ther       Date:  2015-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.